サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1566929

急性虚血性脳卒中診断市場：技術別、エンドユーザー別：世界の機会分析と産業予測、2024年～2033年

Acute Ischemic Stroke Diagnosis Market By Technology , By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 228 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
急性虚血性脳卒中診断市場：技術別、エンドユーザー別：世界の機会分析と産業予測、2024年～2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 228 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

急性虚血性脳卒中診断市場

急性虚血性脳卒中診断市場は、2023年に21億米ドルと評価され、2024年から2033年にかけてCAGR 5.7%で成長し、2033年には36億米ドルに達すると予測されています。

急性虚血性脳卒中（AIS）は、脳への血流が突然遮断され、神経機能障害を引き起こす致死的な疾患です。閉塞は通常、血栓や塞栓が原因で起こり、脳組織の虚血や梗塞を引き起こします。突然の脱力感、会話や理解の困難、体の片側のしびれ、視力障害、激しい頭痛、めまいなどがAISの最も一般的な症状です。AISの即時診断には、臨床的評価とCTまたはMRIによる神経画像診断が必要であり、これは血流を適時に回復させ、脳の損傷を軽減するために極めて重要です。

特に高齢者におけるAISの有病率の増加が、急性虚血性脳卒中診断の需要を押し上げています。高齢者人口は世界中で急激に増加しており、ライフスタイルのダイナミックな変化により、高齢者の間で生命を脅かす疾患の発生が増加しています。さらに、ヘルスケアと診断技術への支出の急増が市場の主要な促進要因となっています。動脈スピンラベリングのような非侵襲的イメージング技術は、最近のAIS診断の動向です。このような技術は非侵襲的に脳血流を測定できるため、迅速かつ正確な診断で組織の生存性を評価するのに役立ちます。

しかし、このような最先端の診断技術に関連する費用は非常に高額であるため、低所得者層がその利点を活用することができず、市場開拓の妨げとなっています。さらに、急性虚血性脳卒中診断に対する償還状況は非常に一貫性がなく、課題も多いため、市場の成長を抑制しています。一方、AISの有病率を低下させるための政府の一貫した取り組みは、市場に有利な機会をもたらすと予想されます。例えば、欧州脳卒中機構は、2018年に欧州の脳卒中アクションプランと呼ばれるイニシアチブを開始し、2030年まで脳卒中の予防行動を改善することを目指しています。

セグメントレビュー

急性虚血性脳卒中診断市場は、技術、エンドユーザー、地域に区分されます。技術別では、CT、MRI、頸動脈超音波、脳血管撮影、心電図、心エコー、その他に分類されます。エンドユーザー別では、病院・診療所、外来手術センター、診断研究所・画像診断センター、その他に分類されます。地域別では、北米、欧州、アジア太平洋、LAMEAで分析されています。

主な調査結果

技術別では、CT（コンピュータ断層検査）分野が2023年の市場で高いシェアを獲得。

エンドユーザー別では、病院・診療所セグメントが2023年に最高株主となった。

地域別では、北米が2023年までに最も高い収益を上げると見られています。

本レポートのカスタマイズが可能です（追加費用とスケジュールが必要です。）

  • 規制ガイドライン
  • クライアントの関心に応じた企業プロファイルの追加
  • 国別または地域別の追加分析-市場規模と予測
  • 企業プロファイルの拡張リスト
  • 過去の市場データ

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 急性虚血性脳卒中診断市場：技術別

  • 市場概要
  • コンピュータ断層撮影
  • 磁気共鳴画像法
  • 頸動脈超音波
  • 脳血管撮影
  • 心電図
  • 心エコー検査
  • その他

第5章 急性虚血性脳卒中診断市場：エンドユーザー別

  • 市場概要
  • 病院および診療所
  • 外来手術センター
  • 診断研究所および画像診断センター
  • その他

第6章 急性虚血性脳卒中診断市場：地域別

  • 市場概要
  • 北米
    • 主な市場動向と機会
    • 米国の急性虚血性脳卒中診断市場
    • カナダ急性虚血性脳卒中診断市場
    • メキシコ急性虚血性脳卒中診断市場
  • 欧州
    • 主な市場動向と機会
    • ドイツの急性虚血性脳卒中診断市場
    • フランス急性虚血性脳卒中診断市場
    • 英国急性虚血性脳卒中診断市場
    • イタリア急性虚血性脳卒中診断市場
    • スペイン急性虚血性脳卒中診断市場
    • その他欧州の虚血性脳卒中診断市場
  • アジア太平洋
    • 主な市場動向と機会
    • 日本の急性虚血性脳卒中診断市場
    • 中国の急性虚血性脳卒中診断市場
    • インドの虚血性脳卒中診断市場
    • オーストラリアの虚血性脳卒中診断市場
    • 韓国の急性虚血性脳卒中診断市場
    • その他アジア太平洋の虚血性脳卒中診断市場
  • ラテンアメリカ・中東・アフリカ
    • 主な市場動向と機会
    • ブラジルの虚血性脳卒中診断市場
    • サウジアラビアの虚血性脳卒中診断市場
    • 南アフリカの虚血性脳卒中診断市場
    • その他のラテンアメリカ・中東・アフリカの急性虚血性脳卒中診断市場

第7章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第8章 企業プロファイル

  • Koninklijke Philips N.V.
  • GE Healthcare
  • Canon Inc.
  • Simens
  • Terumo Corporation
  • Stryker
  • Fujifilm Holdings Corporation
  • Samsung Electronics Co. Ltd
  • F. Hoffmann-La Roche Ltd
  • Boehringer Ingelheim International GmbH
目次
Product Code: A323961

Acute Ischemic Stroke Diagnosis Market

The acute ischemic stroke diagnosis market was valued at $2.1 billion in 2023 and is projected to reach $3.6 billion by 2033, growing at a CAGR of 5.7% from 2024 to 2033.

Acute ischemic stroke (AIS) is a fatal condition that includes abrupt obstruction of blood flow to the brain, leading to neurological dysfunction. The blockage is typically caused due to a thrombus or embolus, resulting in brain tissue ischemia and infarction. Sudden weakness, difficulty speaking or understanding speech, numbness on one side of the body, vision problems, severe headaches, and dizziness are the most common symptoms of AIS. Immediate diagnosis for the condition involves clinical assessment and neuroimaging via CT or MRI, which is pivotal to timely restore the blood flow and reduce brain damage.

Increase in the prevalence of AIS, particularly in the elderly population, is boosting the demand for acute ischemic stroke diagnosis. The elderly population is growing exponentially across the globe and dynamic changes in lifestyle are leading to rise in the occurrence of life-threatening conditions among them. Moreover, surge in expenditure on healthcare and diagnostic technologies is a key driver of the market. Non-invasive imaging techniques such as arterial spin labeling are trending for the diagnosis of AIS in recent times. Such techniques enable measurement of cerebral blood flow non-invasively, hence helping to assess the tissue viability with quick & precise diagnosis.

However, the expense associated with such cutting-edge diagnosis techniques is significantly high which prevents the low-income population from leveraging its benefits, hence hampering the market development. Moreover, the reimbursement landscape for acute ischemic stroke diagnosis is highly inconsistent and challenging, thereby restricting the growth of the market. On the contrary, the consistent efforts by government to reduce the prevalence of AIS is anticipated to present lucrative opportunities for the market. For instance, the European Stroke Organization began an initiative called Stroke Action Plan for Europe in 2018 which aims to improve the preventive action for stroke until 2030.

Segment Review

The acute ischemic stroke diagnosis market is segmented into technology, end user, and region. On the basis of technology, the market is divided into computed tomography, magnetic resonance imaging, carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others. Depending on end user, it is classified into hospitals & clinics, ambulatory surgery centers, diagnostic laboratories and imaging centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of technology, the computed tomography segment acquired high stakes at the market in 2023.

Depending on end user, the hospitals & clinics segment was the highest shareholder in 2023.

Region wise, North America is poised to be the highest revenue generator by 2023.

Competition Analysis

The major players operating in the global acute ischemic stroke diagnosis market include Koninklijke Philips N.V., GE Healthcare, Canon Inc., Simens, Terumo Corporation, Stryker, Fujifilm Holdings Corporation, Samsung Electronics Co. Ltd, F. Hoffmann-La Roche Ltd, and Boehringer Ingelheim International GmbH. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Technology

  • Computed Tomography
  • Magnetic Resonance Imaging
  • Carotid Ultrasound
  • Cerebral Angiography
  • Electrocardiography
  • Echocardiography
  • Others

By End User

  • Hospitals and Clinics
  • Ambulatory Surgery Centers
  • Diagnostic Laboratories and Imaging Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Koninklijke Philips N.V.
    • GE Healthcare
    • Canon Inc.
    • Simens
    • Terumo Corporation
    • Stryker
    • Fujifilm Holdings Corporation
    • Samsung Electronics Co. Ltd
    • F. Hoffmann-La Roche Ltd
    • Boehringer Ingelheim International GmbH

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Technology
  • 4.2. Computed Tomography
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Magnetic Resonance Imaging
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Carotid Ultrasound
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Cerebral Angiography
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country
  • 4.6. Electrocardiography
    • 4.6.1. Key Market Trends, Growth Factors and Opportunities
    • 4.6.2. Market Size and Forecast, By Region
    • 4.6.3. Market Share Analysis, By Country
  • 4.7. Echocardiography
    • 4.7.1. Key Market Trends, Growth Factors and Opportunities
    • 4.7.2. Market Size and Forecast, By Region
    • 4.7.3. Market Share Analysis, By Country
  • 4.8. Others
    • 4.8.1. Key Market Trends, Growth Factors and Opportunities
    • 4.8.2. Market Size and Forecast, By Region
    • 4.8.3. Market Share Analysis, By Country

CHAPTER 5: ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By End User
  • 5.2. Hospitals And Clinics
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Ambulatory Surgery Centers
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Diagnostic Laboratories And Imaging Centers
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Others
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Technology
    • 6.2.3. Market Size and Forecast, By End User
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Acute Ischemic Stroke Diagnosis Market
      • 6.2.5.1. Market Size and Forecast, By Technology
      • 6.2.5.2. Market Size and Forecast, By End User
    • 6.2.6. Canada Acute Ischemic Stroke Diagnosis Market
      • 6.2.6.1. Market Size and Forecast, By Technology
      • 6.2.6.2. Market Size and Forecast, By End User
    • 6.2.7. Mexico Acute Ischemic Stroke Diagnosis Market
      • 6.2.7.1. Market Size and Forecast, By Technology
      • 6.2.7.2. Market Size and Forecast, By End User
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Technology
    • 6.3.3. Market Size and Forecast, By End User
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. Germany Acute Ischemic Stroke Diagnosis Market
      • 6.3.5.1. Market Size and Forecast, By Technology
      • 6.3.5.2. Market Size and Forecast, By End User
    • 6.3.6. France Acute Ischemic Stroke Diagnosis Market
      • 6.3.6.1. Market Size and Forecast, By Technology
      • 6.3.6.2. Market Size and Forecast, By End User
    • 6.3.7. UK Acute Ischemic Stroke Diagnosis Market
      • 6.3.7.1. Market Size and Forecast, By Technology
      • 6.3.7.2. Market Size and Forecast, By End User
    • 6.3.8. Italy Acute Ischemic Stroke Diagnosis Market
      • 6.3.8.1. Market Size and Forecast, By Technology
      • 6.3.8.2. Market Size and Forecast, By End User
    • 6.3.9. Spain Acute Ischemic Stroke Diagnosis Market
      • 6.3.9.1. Market Size and Forecast, By Technology
      • 6.3.9.2. Market Size and Forecast, By End User
    • 6.3.10. Rest of Europe Acute Ischemic Stroke Diagnosis Market
      • 6.3.10.1. Market Size and Forecast, By Technology
      • 6.3.10.2. Market Size and Forecast, By End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Technology
    • 6.4.3. Market Size and Forecast, By End User
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. Japan Acute Ischemic Stroke Diagnosis Market
      • 6.4.5.1. Market Size and Forecast, By Technology
      • 6.4.5.2. Market Size and Forecast, By End User
    • 6.4.6. China Acute Ischemic Stroke Diagnosis Market
      • 6.4.6.1. Market Size and Forecast, By Technology
      • 6.4.6.2. Market Size and Forecast, By End User
    • 6.4.7. India Acute Ischemic Stroke Diagnosis Market
      • 6.4.7.1. Market Size and Forecast, By Technology
      • 6.4.7.2. Market Size and Forecast, By End User
    • 6.4.8. Australia Acute Ischemic Stroke Diagnosis Market
      • 6.4.8.1. Market Size and Forecast, By Technology
      • 6.4.8.2. Market Size and Forecast, By End User
    • 6.4.9. South Korea Acute Ischemic Stroke Diagnosis Market
      • 6.4.9.1. Market Size and Forecast, By Technology
      • 6.4.9.2. Market Size and Forecast, By End User
    • 6.4.10. Rest of Asia-Pacific Acute Ischemic Stroke Diagnosis Market
      • 6.4.10.1. Market Size and Forecast, By Technology
      • 6.4.10.2. Market Size and Forecast, By End User
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Technology
    • 6.5.3. Market Size and Forecast, By End User
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Acute Ischemic Stroke Diagnosis Market
      • 6.5.5.1. Market Size and Forecast, By Technology
      • 6.5.5.2. Market Size and Forecast, By End User
    • 6.5.6. Saudi Arabia Acute Ischemic Stroke Diagnosis Market
      • 6.5.6.1. Market Size and Forecast, By Technology
      • 6.5.6.2. Market Size and Forecast, By End User
    • 6.5.7. South Africa Acute Ischemic Stroke Diagnosis Market
      • 6.5.7.1. Market Size and Forecast, By Technology
      • 6.5.7.2. Market Size and Forecast, By End User
    • 6.5.8. Rest of LAMEA Acute Ischemic Stroke Diagnosis Market
      • 6.5.8.1. Market Size and Forecast, By Technology
      • 6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. Koninklijke Philips N.V.
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. GE Healthcare
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. Canon Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Simens
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. Terumo Corporation
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. Stryker
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Fujifilm Holdings Corporation
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. Samsung Electronics Co. Ltd
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. F. Hoffmann-La Roche Ltd
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. Boehringer Ingelheim International GmbH
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments